Zealthy
Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.
- Semaglutide
- $286/mo (starting dose, plus a separate fee, compounded)
- Tirzepatide
- $351/mo (starting dose, plus a separate fee, compounded)
- Coverage
- 34 states
- Brand-name
- Not confirmed
Weigh Zealthy against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
What to consider
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued FitRX, LLC dba Zealthy a warning letter in September 2025; the letter is public in FDA's warning-letter database
Bottom line — Grade C
Best for: Shoppers who want not currently recommended — listed for transparency and reader awareness only.
Site position #538 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.
Closest here
The rankings grading nearest Zealthy — the realistic shortlist.
Public first and ongoing injection prices, with unresolved monthly-versus-28-day billing and separately qualified oral and branded offers.
Remi Meds is a DTC compounded-GLP-1 telehealth platform offering per-dose-tier compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons.
Basal Health is a national GLP-1 telehealth platform built around a metabolic-medicine framework, positioning GLP-1 therapy as one piece of a five-marker picture — insulin sensitivity, muscle mass, hormonal response, VO2 max, and body fat — with clinician-supervised, adaptive dosing rather than a fixed protocol.
OlleveCare is a small virtual-urgent-care storefront that has added a cash-pay weight-management track using compounded semaglutide and tirzepatide, available across 13 listed states (including DC).
Kova is a GLP-1 weight-loss program from LifeTech Apps Inc, a Delaware company, pairing compounded GLP-1 medication with a companion app that tracks weight, protein intake and side effects.
Shape Vantage is a tirzepatide reseller with a hybrid gray-market profile that does not match the typical compounded-telehealth model.
The 21 rankings nearest this one
- #1 CoreAge Rx89.5
- #2 Sesame Care87.8
- #3 ShedRx87
- #4 Enhance MD84.8
- #5 RxSpan MD84.3
- #6 Ondra Health86.8
- #7 yourEra83.8
- #8 Found83.5
- #9 Trimi86.4
- #10 Invigor Medical86.1
- #11 Vitara RX86
- #12 Gala Health82.9
- #13 Care Clinics85.4
- #14 telos rx85.4
- #15 Gimme Care84.6
- #16 Eden81.6
- #17 AgelessRx84.3
- #18 Fresh Day Meds84.3
- #19 Kongo83.8
- #20 Precision Telemed83.8
- #21 Effecty83.7
Pricing/verification reflect Zealthy's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.